These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26639242)

  • 41. Isolation and quantification of microRNAs from urinary exosomes/microvesicles for biomarker discovery.
    Lv LL; Cao Y; Liu D; Xu M; Liu H; Tang RN; Ma KL; Liu BC
    Int J Biol Sci; 2013; 9(10):1021-31. PubMed ID: 24250247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer.
    Wang J; Zhang X; Wang L; Dong Z; Du L; Yang Y; Guo Y; Wang C
    J Surg Oncol; 2015 Jun; 111(8):992-9. PubMed ID: 25975233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of microRNAs in endocrine cancer metastasis.
    Lima CR; Gomes CC; Santos MF
    Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Controlled ovarian hyperstimulation induced changes in the expression of circulatory miRNA in bovine follicular fluid and blood plasma.
    Noferesti SS; Sohel MM; Hoelker M; Salilew-Wondim D; Tholen E; Looft C; Rings F; Neuhoff C; Schellander K; Tesfaye D
    J Ovarian Res; 2015 Dec; 8():81. PubMed ID: 26645573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
    Yoshizawa S; Umezu T; Saitoh Y; Gotoh M; Akahane D; Kobayashi C; Ohyashiki JH; Ohyashiki K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urinary-exosomal miR-2909: A novel pathognomonic trait of prostate cancer severity.
    Wani S; Kaul D; Mavuduru RS; Kakkar N; Bhatia A
    J Biotechnol; 2017 Oct; 259():135-139. PubMed ID: 28764970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
    Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
    Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
    [No Abstract]   [Full Text] [Related]  

  • 49. MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples.
    Kent MS; Zwingenberger A; Westropp JL; Barrett LE; Durbin-Johnson BP; Ghosh P; Vinall RL
    BMC Vet Res; 2017 Nov; 13(1):339. PubMed ID: 29141625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of miRNAs in urine of prostate cancer patients.
    Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
    Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exosome-derived miRNAs and ovarian carcinoma progression.
    Vaksman O; Tropé C; Davidson B; Reich R
    Carcinogenesis; 2014 Sep; 35(9):2113-20. PubMed ID: 24925027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
    Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
    Zhang J; Le TD; Liu L; He J; Li J
    Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes.
    Yagi Y; Ohkubo T; Kawaji H; Machida A; Miyata H; Goda S; Roy S; Hayashizaki Y; Suzuki H; Yokota T
    Neurosci Lett; 2017 Jan; 636():48-57. PubMed ID: 27780738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urinary Exosomal miR-193a Can Be a Potential Biomarker for the Diagnosis of Primary Focal Segmental Glomerulosclerosis in Children.
    Huang Z; Zhang Y; Zhou J; Zhang Y
    Biomed Res Int; 2017; 2017():7298160. PubMed ID: 28246603
    [No Abstract]   [Full Text] [Related]  

  • 56. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer.
    Nedaeinia R; Manian M; Jazayeri MH; Ranjbar M; Salehi R; Sharifi M; Mohaghegh F; Goli M; Jahednia SH; Avan A; Ghayour-Mobarhan M
    Cancer Gene Ther; 2017 Feb; 24(2):48-56. PubMed ID: 27982021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of MicroRNA Content in Plasma and Urine Indicates the Existence of a Transrenal Passage of Selected MicroRNAs.
    Pazourkova E; Pospisilova S; Svobodova I; Horinek A; Brisuda A; Soukup V; Hrbacek J; Capoun O; Mares J; Hanus T; Babjuk M; Korabecna M
    Adv Exp Med Biol; 2016; 924():97-100. PubMed ID: 27753026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes.
    Kitdumrongthum S; Metheetrairut C; Charoensawan V; Ounjai P; Janpipatkul K; Panvongsa W; Weerachayaphorn J; Piyachaturawat P; Chairoungdua A
    Life Sci; 2018 Oct; 210():65-75. PubMed ID: 30165035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of microRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer.
    Wilczynski M; Danielska J; Domanska-Senderowska D; Dzieniecka M; Szymanska B; Malinowski A
    Acta Obstet Gynecol Scand; 2018 May; 97(5):560-569. PubMed ID: 29355888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.